Advanced Oncotherapy (AVO) wins Best Technology Award at the AIM Awards 2015.
Sponsored by | Sanlam Securities UK
Picture shows, left to right:
David Snell, Partner and AIM Leader, PwC; David Worlidge, Director, Corporate Finance, Sanlam Securities UK; Robert Rose, Operations and Manufacturing Director, Advanced Oncotherapy plc and Graham Pughe, Chief Accounting Officer and Vice President of Finance, Advanced Oncotherapy plc (winner); and Bev Turner, awards presenter.
